guy
vernet
fondat
lyon
franc
genom
scienc
studi
genom
live
organ
main
driver
compani
special
genom
human
genom
sequenc
technolog
breakthrough
achiev
improv
speed
qualiti
human
genom
sequenc
reduc
cost
sanger
sequenc
use
human
genom
project
result
first
wholegenom
sequenc
budget
billion
five
year
later
result
obtain
month
million
voelkerd
et
al
nation
human
genom
research
institut
nhgri
part
nih
award
million
grant
genom
grant
develop
innov
sequenc
technolog
inexpens
effici
enough
sequenc
person
dna
routin
part
biomed
research
health
care
less
genom
project
china
germani
uk
us
collabor
current
sequenc
whole
genom
individu
worldwid
identifi
genet
variat
via
et
al
microarray
technolog
develop
address
mostli
need
human
genom
may
scientif
paper
use
affymetrix
santa
clara
ca
usa
proprietari
microarray
technolog
list
web
site
compani
wwwaffymetrixcom
microarray
also
use
resequenc
gene
express
monitor
infecti
agent
new
sequenc
technolog
instrument
refer
nextgener
sequenc
ng
appear
last
year
interestingli
first
use
sequenc
whole
genom
human
pathogen
mycoplasma
genitalia
marguli
et
al
escherichia
coli
shendur
et
al
understand
host
vector
pathogen
genom
well
transcriptom
epigenom
modif
follow
infect
cours
diseas
treatment
ultim
lead
person
medicin
genom
characterist
import
tailor
treatment
snyder
et
al
sever
biotech
compani
creat
last
year
develop
market
system
analysi
genom
mani
scientist
issu
univers
sinc
often
acquir
larger
compani
major
player
field
vitro
diagnost
custom
compani
involv
genom
public
privat
organ
research
laboratori
univers
institut
differ
need
imposs
address
singl
technolog
instrument
due
high
price
equip
mainten
frequent
need
instrument
upgrad
platform
serv
need
sever
research
laboratori
provid
servic
scientif
commun
emerg
provid
full
set
equip
dedic
human
resourc
wellcom
trust
sanger
institut
cambridg
uk
exampl
platform
link
bioinformat
resourc
serv
differ
research
project
includ
pathogen
genet
group
explor
parasit
especi
malariaand
virus
genom
broad
institut
cambridg
usa
anoth
exampl
genomesequenc
platform
also
consid
fungi
bacteria
viru
genom
j
craig
venter
institut
notforprofit
privat
organ
base
rockvil
maryland
usa
scientist
staff
squar
feet
laboratori
oper
sever
resourc
center
sequenc
genotyp
function
genom
bioinformat
infecti
diseas
genom
china
beij
genom
institut
bgi
chines
academi
scienc
base
shenzhen
hong
kong
staff
end
acquir
hiseq
ng
machin
illumina
san
diego
ca
usa
sequenc
servic
research
project
infecti
diseas
like
sever
acut
respiratori
syndrom
sar
coronaviru
cyranoski
larg
institut
numer
worldwid
howev
attract
larg
intern
budget
gener
import
sell
genom
compani
term
instrument
mainten
reagent
genom
platform
often
provid
servic
remain
competit
return
invest
thu
repres
potenti
custom
genom
compani
list
compani
public
facil
provid
dnasequenc
servic
differ
part
world
found
http
wwwnucleicscom
dnasequencingsupportsequencingservicereviewshtml
quit
complet
although
mention
organ
like
illumina
beckman
coulter
wellcom
trust
sanger
institut
use
tool
scientist
need
choos
servic
compani
includ
avail
price
dnasequenc
instrument
use
facil
specif
dna
templat
primer
requir
sampl
ship
sequenc
facil
contact
detail
whether
dnasequenc
facil
glpfda
certifi
dnasequencingrel
servic
offer
facil
facil
worldwid
includ
mani
univers
usa
canada
mani
compliant
good
clinic
practic
gcp
good
laboratori
practic
glp
good
manufactur
practic
gmp
clinic
diagnost
servic
clinic
laboratori
improv
amend
clia
regul
pharmaceut
compani
also
need
complex
genom
data
r
purposesnew
molecul
vaccin
develop
toxic
pharmacokinet
studiesalthough
trend
outsourc
upstream
research
public
laboratori
biotechnolog
compani
extrem
data
complex
highlevel
public
privat
laboratori
hospit
use
technolog
base
genom
inform
diagnost
forens
surveil
need
although
current
central
due
requir
sophist
equip
rel
high
skill
techniqu
probabl
reach
custom
near
futur
final
pharmaceut
agrofood
compani
also
use
lowcomplex
data
qualiti
control
purpos
ensur
product
biosafeti
wholegenom
sequenc
comparativegenom
sequenc
target
resequenc
first
need
scientist
sequenc
microb
genom
wholegenom
sequenc
virus
bacteria
archeal
speci
deposit
genbank
releas
wooley
et
al
number
grow
rapidli
emphasi
speci
pathogen
anim
plant
sequenc
identifi
singl
nucleotid
polymorph
snp
insert
delet
indel
larg
chromosom
rearrang
structur
copi
number
chang
refer
sequenc
establish
given
speci
need
resequenc
ie
comparison
sequenc
new
isol
refer
sequenc
identifi
differ
her
palsson
comparison
concern
whole
genom
target
gene
interest
modif
expect
consequ
phenotyp
scientist
use
data
fundament
research
annot
gene
understand
genom
organ
classifi
speci
studi
evolut
knowledg
genom
organ
combin
function
genom
basi
understand
pathobiolog
mechan
infecti
agent
among
downstream
applic
develop
new
drug
vaccin
diagnost
includ
establish
resist
escap
profil
surveil
network
also
use
genom
inform
monitor
pathogen
evolut
resist
treatment
cross
host
speciat
barrier
increas
transmiss
virul
new
field
investig
studi
microbiom
metagenom
wooley
et
al
consist
systemat
sequenc
nucleic
acid
given
ecolog
nich
gut
upper
respiratori
tract
skinto
identifi
microb
allow
us
character
normal
flora
exampl
differ
age
life
interact
flora
pathogen
agent
infect
particular
exchang
genet
materi
confer
resist
virul
applic
pharmaceut
diagnost
agrofood
compani
import
studi
microbiom
also
potenti
applic
forens
sequenc
bacteriom
trace
left
use
identifi
peopl
flora
present
skin
signatur
depend
food
habit
environ
diseas
transcriptom
analysi
character
code
noncod
transcript
activ
organ
without
priori
assumpt
annot
snp
map
refer
genom
character
transcript
isoform
regulatori
rna
splice
junction
determin
rel
abund
transcript
gene
express
analysi
analysi
differenti
gene
express
import
host
pathogen
well
vector
transmiss
diseas
mostli
insect
human
plant
anim
cell
studi
confront
infect
identifi
mechan
target
pathogen
resist
infect
pathogen
gene
express
infect
cell
import
area
investig
may
reveal
pathobiolog
mechan
target
new
drug
epigenom
analysi
studi
chromatin
structur
gene
regul
cpg
methyl
histon
modif
interact
besid
fundament
research
function
genom
find
applic
pharmaceut
compani
new
antiinfect
drug
diagnost
compani
identifi
new
biomark
diagnost
diseas
treatment
monitor
genom
research
gener
tremend
amount
inform
among
sequenc
use
detect
infect
pathogen
speci
simpl
molecular
techniqu
like
polymeras
chain
reaction
pcr
transcriptionmedi
amplif
tma
nucleic
acid
sequencebas
amplif
nasba
quantit
also
help
monitor
treatment
efficaci
exampl
human
immunodefici
viru
hiv
hepat
virus
syndromebas
approach
ie
detect
multipl
pathogen
respons
diseas
pneumonia
fever
neurolog
diseas
diarrhea
may
also
use
signatur
sequenc
identifi
infect
variant
specif
phenotyp
given
virul
host
specif
resist
treatment
help
patient
care
epidemiolog
surveil
latter
signatur
entir
gene
acquir
horizont
transmiss
either
plasmid
recombin
individu
snp
group
snp
carri
uniqu
differ
gene
indel
even
modifi
express
gene
comprehens
assay
associ
pathogen
identif
pathogen
type
identif
virul
resist
marker
may
prove
valuabl
chronic
infect
like
hiv
hepat
viru
infect
tuberculosi
microarray
sanger
sequenc
ng
gener
larg
quantiti
data
necessari
wholegenom
resequenc
target
resequenc
gene
copi
number
variat
gene
express
analysi
chromosom
structur
chang
interact
howev
microarray
analysi
definit
requir
priori
knowledg
sequenc
sequenc
allow
determin
unknown
sequenc
ng
allow
rapid
lowcost
wholegenom
sequenc
metagenom
well
massiv
parallel
process
multipl
specimen
less
complex
technolog
like
pyrosequenc
lowto
mediumdens
microarray
use
target
sequenc
resequenc
one
genom
region
interest
patient
manag
molecular
epidemiolog
molecular
diagnost
use
pcr
tma
nasba
loopmedi
isotherm
amplif
lamp
mani
applic
infecti
diseas
research
epidemiolog
surveil
treatment
howev
address
domain
activ
exploit
data
issu
genom
research
least
compani
provid
microarray
identifi
usa
europ
north
shore
lij
research
institut
http
wwwnslijgenet
orgmicroarray
propos
lowto
mediumdens
custom
array
glass
plate
bead
dna
probe
either
spot
synthes
situ
use
varieti
technolog
includ
print
finepoint
pin
onto
glass
slide
photolithographi
use
premad
mask
photolithographi
use
dynam
micromirror
devic
inkjet
print
electrochemistri
microelectrod
array
recent
review
use
microarray
clinic
microbiolog
see
miller
tang
focu
compani
provid
highdens
microarray
affymetrix
genechip
technolog
base
photolithographi
synthes
probe
situ
array
invent
late
public
retriev
affymetrix
databas
key
word
viru
bacteria
parasit
fungi
current
compani
platform
gc
k
clear
ce
mark
vitro
diagnost
use
consist
scanner
fluidic
station
affymetrix
molecular
diagnost
softwar
amd
data
interpret
human
genom
plu
array
analyz
transcript
human
genom
allow
gene
express
profil
cell
infect
variou
pathogen
sever
commerci
array
address
human
pathogen
e
coli
array
contain
probe
set
detect
transcript
strain
e
coli
three
pathogen
strain
e
coli
includ
approxim
probe
set
gene
present
four
strain
e
coli
entir
open
read
frame
orf
e
coli
intergen
region
well
probe
set
variou
antibiot
resist
marker
staphylococcu
aureu
genom
array
allow
analysi
express
sequenc
four
strain
aureu
contain
probe
set
aureu
orf
studi
forward
revers
orient
intergen
region
pseudomona
aeruginosa
genom
array
repres
annot
genom
p
aeruginosa
strain
includ
proteincod
sequenc
trna
gene
repres
ribosom
rna
cluster
gene
present
strain
addit
probe
set
correspond
intergen
region
exceed
base
pair
includ
plasmodiumanophel
genom
array
includ
probe
set
plasmodium
falciparum
transcript
approxim
anophel
gambia
transcript
sar
resequenc
array
provid
standard
assay
complet
sequenc
analysi
sar
coronaviru
marcyletoil
franc
develop
sever
resequenc
microarray
cover
pathogen
genom
mycobacterium
tuberculosi
array
base
two
sequenc
databas
one
speci
identif
mycobacteria
uniqu
rrna
sequenc
correspond
phenotyp
speci
detect
tuberculosi
rifampin
resist
rpob
troesch
et
al
sougakoff
et
al
aureu
array
tile
rdna
sequenc
identifi
staphylococcu
speci
couzinet
grla
gyra
grlb
gyrb
gene
presenc
mutat
involv
fluoroquinolon
resist
couzinet
multilocu
sequenc
type
mlst
aureu
strain
van
leeuwen
et
al
hiv
microarray
design
detect
antiretrovir
resist
mutat
simultan
gag
cleavag
site
proteas
revers
transcriptas
integras
gonzalez
et
al
similarli
hepat
b
viru
hbv
microarray
design
detect
mutat
delet
insert
posit
determin
genotyp
hbv
tran
et
al
pa
et
al
roch
nimblegen
madison
wi
usa
manufactur
custom
highdens
dna
array
base
proprietari
maskless
array
synthes
ma
technolog
use
digit
micromirror
devic
dmd
combin
dna
synthesi
chemistri
allow
million
uniqu
probe
featur
singl
array
array
synthes
standards
glass
microscop
slide
compat
rang
hybrid
wash
scan
instrument
new
gener
array
oligo
base
length
synthes
increas
sensit
specif
reproduc
recent
roch
nimblegen
introduc
sequenc
captur
array
produc
target
sequencingreadi
sampl
use
ng
instrument
high
densiti
nimblegen
array
long
oligonucleotid
use
hybrid
either
whole
human
exom
human
genom
region
interest
hybrid
purifi
human
sequenc
elut
amplifi
sequenc
although
current
restrict
human
genom
recent
wheat
rapese
technolog
may
prove
valuabl
infecti
diseas
genom
agil
technolog
santa
clara
ca
usa
febit
heidelberg
germani
also
market
captur
microarray
ng
parallel
sequenc
clonal
amplifi
singl
dna
molecul
iter
cycl
polymerasebas
extens
oligonucleotid
ligat
take
place
flow
cell
technolog
revolution
aspect
genom
wholegenom
sequenc
target
resequenc
metagenom
gene
express
profil
epigenom
interact
studi
chipseq
recent
review
ng
see
holt
jone
voelkerd
et
al
life
scienc
platform
genom
sequenc
flx
system
use
sequencingbysynthesi
sb
technolog
de
novo
sequenc
resequenc
whole
genom
target
dna
region
metagenom
rna
analysi
chemistri
use
sequenc
describ
figur
autom
use
magnet
bead
technolog
simplifi
emulsionpcr
allow
librari
prepar
genom
sampl
hour
singl
tube
elimin
clone
coloni
pick
recogn
advantag
flx
system
compar
ng
platform
gener
longest
singl
read
bp
long
pair
end
read
kb
kb
kb
may
compani
introduc
gs
junior
system
provid
integr
sequenc
bioinformat
solut
size
typic
desktop
laser
printer
compani
announc
improv
sequenc
chemistri
next
next
base
base
origin
dna
sampl
first
fragment
dna
doublehelix
melt
singl
strand
polya
tail
ad
dna
molecul
billion
singl
dna
molecul
captur
proprietari
surfac
within
flow
cell
serv
templat
sb
process
genom
dna
fragment
polya
tail
ad
dna
molecul
captur
oligo
dt
primer
insid
flow
cell
tsm
process
cyclic
process
involv
multipl
round
synthesi
use
label
nucleotid
wash
imag
cleav
fluoresc
label
desir
read
length
achiev
sourc
copyright
helico
bioscienc
corp
right
reserv
increas
read
length
bp
publish
studi
use
technolog
among
concern
infecti
diseas
technolog
found
applic
metagenom
identif
new
arenaviru
transplant
patient
palacio
et
al
character
microflora
oral
caviti
gut
keijser
et
al
turnbaugh
et
al
illumina
creat
exploit
right
beadarray
technolog
develop
tuft
univers
hiseq
tm
platform
base
sb
chemistri
gener
read
bp
pair
end
read
allow
assembl
long
scaffold
figur
librari
prepar
cluster
gener
done
cbot
autom
cluster
gener
system
significantli
reduc
handson
time
compar
emulsionpcr
sequenc
genom
done
one
flow
cell
simultan
flow
cell
analyz
epigenom
transcriptom
public
illustr
versatil
illumina
ng
technolog
recent
public
infecti
diseas
includ
trichinella
spirali
webb
rosenth
p
falciparum
jiang
et
al
viru
discoveri
drosophila
cell
adult
mosquito
wu
et
al
methicillinresist
staphylococcu
aureu
mrsa
molecular
epidemiolog
harri
et
al
burkholderia
cenocepacia
therapeut
target
yoderhim
et
al
pasteurella
multocida
virul
factor
steen
et
al
illumina
platform
versatil
three
ng
platform
requir
clonal
amplif
associ
gigabas
output
read
length
bp
life
technolog
creat
combin
invitrogen
corpor
appli
biosystem
inc
appli
biosystem
commerci
ng
platform
call
solid
chemistri
use
platform
describ
figur
base
emulsionpcr
oligonucleotid
ligat
solid
platform
two
flow
cell
allow
two
independ
experi
time
multiplex
sampl
appli
biosystem
propos
autom
solut
reproduc
templat
bead
prepar
less
h
handson
time
ez
system
solid
platform
gener
shortest
read
length
among
three
platform
make
less
versatil
variou
applic
howev
futur
evolut
solid
platform
solid
solid
pi
gener
longer
read
bp
helico
bioscienc
corpor
cambridg
usa
commerci
first
platform
allow
sequenc
singl
dna
molecul
therebi
avoid
bias
due
amplif
three
compani
describ
earlier
helico
recipi
genom
grant
chemistri
use
helico
genet
analysi
system
base
tsm
technolog
figur
singlestrand
dna
molecul
gener
librari
tag
polya
tail
attach
proprietari
surfac
densiti
molecul
per
squar
centimet
sequenc
synthesi
system
instal
sever
research
center
usa
europ
helico
platform
use
first
singlemolecul
wholegenom
sequenc
pushkarev
et
al
studi
achiev
averag
coverag
human
genom
detect
million
snp
novel
valid
genotyp
array
demonstr
concord
unbias
natur
singlemolecul
sequenc
approach
also
allow
detect
copi
number
variat
genom
ng
technolog
gener
much
higher
amount
data
wellestablish
abi
sanger
platform
analysi
gigabas
terabas
requir
complex
softwar
solut
list
softwar
use
ng
platform
found
voelkerd
et
al
howev
perform
claim
manufactur
may
overestim
harismendi
et
al
compar
platform
life
scienc
illumina
appli
biosystem
kb
human
genom
sampl
although
illumina
appli
biosystem
produc
largest
amount
data
respect
usabl
qualiti
filtrat
contrast
data
gener
platform
usabl
three
technolog
bias
induc
heterogen
coverag
base
along
sequenc
platform
show
lowest
variabl
among
uniqu
repetit
sequenc
wherea
abi
illumina
platform
tend
affect
high
adenin
thymin
content
ng
platform
tend
better
detect
indel
abi
sanger
platform
sequenc
singl
strand
expect
abi
sanger
sequenc
error
rate
approxim
care
comparison
ng
reveal
fals
posit
fals
neg
rate
overal
sequenc
accuraci
ng
platform
high
abil
detect
variant
platform
lowest
sensit
illumina
platform
abi
platform
last
two
technolog
less
specif
overal
ng
platform
need
improv
uniform
perbas
sequenc
coverag
accuraci
lower
poorli
cover
region
new
technolog
base
nanopor
current
explor
develop
platform
singledna
molecul
sequenc
branton
et
al
nanoporebas
devic
provid
singlemolecul
detect
analyt
capabl
achiev
electrophoret
drive
molecul
solut
nanoscal
pore
nanopor
provid
highli
confin
space
within
singl
nucleic
acid
polym
analyz
high
throughput
one
varieti
mean
perfect
process
enforc
narrow
pore
ensur
nativ
order
nucleobas
polynucleotid
reflect
sequenc
signal
detect
kilobas
length
polym
singlestrand
genom
dna
rna
small
molecul
eg
nucleosid
identifi
character
without
amplif
label
uniqu
analyt
capabl
make
inexpens
rapid
dna
sequenc
possibl
research
develop
overcom
current
challeng
nanopor
identif
success
nucleotid
dna
strand
offer
prospect
thirdgener
instrument
sequenc
diploid
mammalian
genom
approxim
approxim
h
oxford
nanopor
technolog
http
wwwnanoporetechcom
oxford
uk
first
gener
dnasequenc
technolog
use
protein
nanopor
combin
process
enzym
multiplex
silicon
chip
eleg
scalabl
system
uniqu
potenti
transform
speed
cost
dna
sequenc
futur
gener
may
interrog
singl
strand
dna
may
use
solidst
nanopor
improv
speed
cost
lingvita
http
wwwlingvitaecom
oslo
sweden
eid
et
al
pacif
bioscienc
menlo
park
ca
usa
design
prototyp
instrument
abl
sequenc
singl
dna
molecul
use
dna
polymeras
base
observ
tempor
incorpor
label
nucleotid
take
place
nanophoton
structur
drastic
reduc
volum
observ
current
prototyp
abl
multiplex
structur
allow
sequenc
small
viral
bacteri
genom
high
accuraci
microarray
ng
revolution
genom
drastic
increas
scientist
access
tremend
amount
inform
genom
gene
express
decreas
timetoresult
handson
time
cost
research
need
technolog
well
understood
still
repres
small
although
rapidli
grow
market
total
market
ng
evalu
million
http
wwwresearchandmarketscomreportinfoasp
market
function
genom
billion
annual
growth
rate
http
wwwresearchandmarketscomreportinfoasp
real
develop
sale
compani
propos
technolog
genom
mostli
come
diagnost
applic
human
anim
health
genom
research
translat
molecular
diagnost
field
human
genet
oncolog
infecti
diseas
sever
vitro
diagnost
compani
propos
instrument
reagent
detect
sequenc
signatur
diagnosi
treatment
monitor
applic
howev
current
clinic
need
mostli
requir
lowcomplex
genet
inform
cover
multiplex
realtim
amplif
revers
hybridizationbas
line
probe
assay
lowdens
microarray
simpl
sequenc
platform
like
pyromark
platform
place
technolog
gener
complex
dataset
clinic
applic
still
defin
develop
applic
requir
clinic
valid
valu
complex
sequenc
inform
strong
effort
clinician
educ
benefit
also
requir
cost
instrument
reagent
decreas
technolog
becom
easier
use
robust
major
compani
cite
chapter
make
effort
simplifi
equip
reduc
cost
per
analysi
affymetrix
recent
launch
new
afford
smaller
platform
geneatla
along
microarray
strip
format
enabl
user
process
two
strip
per
day
eight
strip
per
week
life
scienc
announc
releas
gs
junior
system
scale
suit
need
individu
laboratori
rapid
sequenc
amplicon
target
human
resequenc
studi
de
novo
sequenc
microbi
small
genom
pathogen
detect
illumina
recent
launch
genom
analyz
iie
lower
cost
make
technolog
access
laboratori
variou
size
similarli
appli
biosystem
announc
less
expens
lowthroughput
benchtop
platform
gb
per
run
allow
shorter
timestoresult
qiagen
hilden
germani
market
rel
simpl
low
footprint
platform
pyromark
realtim
sequencebas
detect
quantif
sequenc
variant
epigenet
methyl
use
pyrosequenc
technolog
instrument
process
sampl
min
platform
afford
midsiz
laboratori
allow
analysi
cpg
methyl
snp
insertiondelet
short
tandem
repeat
str
variabl
gene
copi
number
